10 unknown, 8 completed, 1 enrolling by invitation, 1 not yet recruiting. 8 Not applicable, 5 Phase 2, 4 Phase 4, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 6, Enrolling by invitation 1, Not yet recruiting 1 |
| Phase 2 | 5 | Unknown 5 |
| Phase 4 | 4 | Unknown 3, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Nanchang University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comorbidity-Oriented Primary Care and Integrated Management for Hypertension and Diabetes Mellitus Integrated Comorbidity Management Package, Usual Care intervention - Hypertension, Diabete Type 2 | Not applicable | Not yet recruiting | Nanchang University | 960 | 2026-05-01 | 2026-04-14 |
| A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer robotic natural orifice specimen extraction surgery, robotic transabdominal specimen extraction surgery - Natural Orifice Specimen Extraction Surgery, Robotic Surgery | Not applicable | Enrolling by invitation | Nanchang University | 100 | 2024-10-01 | 2026-01-30 |
| Prevalence and Risk Indicators of Peri-implant Diseases in China Peri-Implantitis | Unknown | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 500 | 2024-01-31 | 2024-01-17 | |
| Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans Raspberry ketone - Obesity, Diabetes | Early Phase 1 | Completed | Nanchang University | 60 | 2024-01-10 | 2024-11-08 |
| External Application of Mirabilite to Promote Recovery in Patients After Gastrointestinal Surgery Topical Mirabilite Application for Postoperative Gastrointestinal Patients, Standard Postoperative Care for Gastrointestinal Patients - Gastrointestinal Surgery, Mirabilite | Not applicable | Completed | Nanchang University | 301 | 2023-10-01 | 2024-11-22 |
| Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer robotic natural orifice specimen extraction surgery, robotic transabdominal specimen extraction surgery - Natural Orifice Specimen Extraction Surgery, Middle Rectal Cancer | Not applicable | Completed | Nanchang University | 150 | 2023-01-01 | 2026-01-30 |
| The Application Value of da Vinci Linear Cutting Stapler SureForm in Robotic Anus Preserving Surgery for Rectal Cancer Surform - Rectal Cancer, Robotic | Not applicable | Completed | Nanchang University | 276 | 2022-12-29 | 2025-05-28 |
| Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib Gefitinib, Anlotinib - Non-small Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | Unknown | Second Affiliated Hospital of Nanchang University | 240 | 2020-05-01 | 2020-04-24 |
| The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC molecular targeted therapies, Brain Radiotherapy - Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Unknown | Second Affiliated Hospital of Nanchang University | 100 | 2019-12-01 | 2019-12-10 |
| Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis Osimertinib, Bevacizumab - Leptomeningeal Metastasis, Non-small Cell Lung Cancer | Phase 2 | Unknown | Second Affiliated Hospital of Nanchang University | 80 | 2019-11-01 | 2019-11-04 |
| Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma lymphadenectomy - Intrahepatic Cholangiocarcinoma | Not applicable | Completed | First Affiliated Hospital Xi'an Jiaotong University | 260 | 2019-01-10 | 2021-12-09 |
| Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer Osimertinib, Bevacizumab - Leptomeningeal Metastasis, Non-small Cell Lung Cancer | Phase 2 | Unknown | Second Affiliated Hospital of Nanchang University | 20 | 2017-10-01 | 2020-06-11 |
| The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg peginterferon alfa - Chronic Hepatitis B | Phase 4 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 200 | 2016-08-01 | 2018-05-22 |
| HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients peginterferon alfa - Chronic Hepatitis B | Phase 4 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 200 | 2016-08-01 | 2018-05-22 |
| The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg Peginterferon alfa - Chronic Hepatitis B | Phase 4 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 200 | 2016-04-01 | 2019-01-15 |
| Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Amlodipine, amlodipine-FA tablet, low dose group, amlodipine-FA tablet ,high dose group - Essential Hypertension | Phase 2 / Phase 3 | Unknown | Shenzhen Ausa Pharmed Co.,Ltd | 756 | 2013-01-01 | 2013-05-08 |
| Repeatability and Agreement of Anterior Segment Optical Coherence Tomography (AS-OCT) and Thermography EyeGiene - Dry Eye Syndromes | Not applicable | Completed | Singapore National Eye Centre | 40 | 2011-06-01 | 2013-02-21 |
| Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial Proteinuria, HBVe-antigen | Unknown | Nanchang University | 10 | 2010-01-01 | 2010-06-29 | |
| 5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy 5 Fluorouracil with hyaluronic acid, 5 Fluorouracil - Glaucoma, Trabeculectomy | Phase 4 | Completed | Singapore National Eye Centre | 50 | 2008-02-01 | 2010-05-12 |
| Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids solu medrol, a steroid-free immunosuppression protocol - Immunosuppression, Hepatocellular Carcinoma | Not applicable | Completed | Shanghai Jiao Tong University School of Medicine | 300 | 2005-01-01 | 2010-06-04 |
Carcinoma, Non-Small-Cell Lung (4) · Hepatitis B, Chronic (3) · Hypertension (2) · Meningeal Carcinomatosis (2) · Anastomotic Leak (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dry Eye Syndromes (1) · Essential Hypertension (1) · Glaucoma (1) · Hyperhomocysteinemia (1) · Lymphatic Metastasis (1)
Bevacizumab (2) · osimertinib (2) · peginterferon alfa-2a (2) · peginterferon alfa-2b (2) · Amlodipine (1) · Contraceptives, Oral (1) · Fluorouracil (1) · Gefitinib (1) · Hyaluronic Acid (1) · Lymph Node Excision (1) · Methylprednisolone (1) · Molecular Targeted Therapy (1) · Population Groups (1) · anlotinib (1) · raspberry ketone (1)
China (14) · Singapore (2)
Liu Anwen, Phd (4) · Gaosi XU, MD & PhD (1) · Louis Tong, PhD (1) · Tina TL Wong, PhD (1) · Xu-Feng Zhang, MD,PhD (1) · Ye ShanPing Dr. Ye (1) · Yi Lv, MD, PhD (1) · Yiqun Wu (1) · Yong Huo, MD (1) · Zhi-Hai Peng, MD (1)
PMID 31751012, PMID 10999768, PMID 11452123, PMID 12750523, PMID 16757720, PMID 17229875, PMID 17374728, PMID 17645714, PMID 17889125, PMID 17894407, PMID 18577994, PMID 19459814, PMID 19502970, PMID 19692680, PMID 19692684, PMID 19801201, PMID 19857686, PMID 20022809, PMID 20966921, PMID 21041710, PMID 21410411, PMID 21472002, PMID 22012633, PMID 22134072, PMID 22487432, PMID 23129122, PMID 23594426, PMID 24021541, PMID 24312144, PMID 24419416, PMID 24893891, PMID 25829397, PMID 25907450, PMID 26148750, PMID 26823294, PMID 27343440, PMID 27458945, PMID 28105214, PMID 28126333, PMID 28212993, PMID 28627678, PMID 28958502, PMID 29151359, PMID 29307353, PMID 29700687, PMID 29782558, PMID 30017884, PMID 30059262, PMID 30207593, PMID 30783814